Sign inJoin waitlistJoin the waitlist

Dale Shepard

Assistant Professor, Department of Medicine, School of Medicine · Case Western Reserve University

Credentials: · · · ·

History

Case Western Reserve University
Present

Cleveland Clinic
2007–2009
Cleveland Clinic
2003–2006
Ohio State University College of Medicine
1999–2003

Research

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Cancer Discovery · 2020 · 289 citations
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial
The Lancet Oncology · 2016 · 199 citations
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
Journal of Neuro-Oncology · 2010 · 154 citations

Nathan Mesko
9 papers · 1 as a fellow
Lukas Nystrom
8 papers
Jacob Scott
6 papers · 3 as a resident
Brian Rubin
5 papers
Chirag Shah
5 papers
GC
Gannon Curtis
5 papers · 3 as a resident
Jorge Garcia
5 papers · 2 as a fellow
Joshua Lawrenz
5 papers · 4 as a resident
Peter Anderson
5 papers
Robert Dreicer
5 papers
Shauna Campbell
5 papers · 1 as a resident
Brian Rini
4 papers

Clinical trials

A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
Principal investigator · Terminated · Phase 1
Pfizer
2015–2017
Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies
Principal investigator · Terminated · Phase 1
Dale Shepard, MD, PhD
2011–2012
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2032
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Site PI · Recruiting · Phase 1
Pierre Fabre Medicament
2021–2029